{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:47:33Z","timestamp":1762253253166,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIH National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["T32 DA022981","GM110702"],"award-info":[{"award-number":["T32 DA022981","GM110702"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DEA\/FDA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.drugalcdep.2020.107850","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T11:39:43Z","timestamp":1578915583000},"page":"107850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation"],"prefix":"10.1016","volume":"208","author":[{"given":"Michael D.","family":"Berquist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Leth-Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Langgaard","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.107850_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/02791072.2015.1094156","article-title":"The psychopharmacology of \u00b13,4 methylenedioxymethamphetamine and its role in the treatment of posttraumatic stress disorder","volume":"47","author":"Amoroso","year":"2015","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0010","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/tx990084t","article-title":"Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity","volume":"12","author":"Bai","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3565(25)39191-3","article-title":"Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites","volume":"242","author":"Battaglia","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0020","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FBP.0000000000000310","article-title":"Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats","volume":"28","author":"Berquist","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/syn.1032","article-title":"Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine","volume":"40","author":"Callahan","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00204-003-0510-7","article-title":"Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates","volume":"78","author":"Carvalho","year":"2004","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.neuroscience.2007.03.028","article-title":"Neurotoxicity mechanisms of thioether ecstasy metabolites","volume":"146","author":"Capela","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1192\/bjp.159.5.713","article-title":"\u2019Ecstasy\u2019 psychosis and flashbacks","volume":"159","author":"Creighton","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.128785","article-title":"Accumulation of neurotoxic thioether metabolites of 3,4-(\u00b1)-methylenedioxymethamphetamine in rat brain","volume":"324","author":"Erives","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00213-002-1261-5","article-title":"Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice","volume":"166","author":"Fantegrossi","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","article-title":"In vivo effects of abused \u2018bath salt\u2019 constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity","volume":"38","author":"Fantegrossi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms? Prog","volume":"84","author":"Feduccia","year":"2018","journal-title":"Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.09.004","article-title":"Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice","volume":"134","author":"Gannon","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0091-3057(92)90405-5","article-title":"Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline","volume":"43","author":"Glennon","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/1064-1297.8.3.415","article-title":"A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+\/-)-MDMA in rats","volume":"8","author":"Goodwin","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0085","first-page":"8","article-title":"Deuterium medicinal chemistry: a new approach to drug discovery and development","volume":"2","author":"Harbeson","year":"2014","journal-title":"Medchem. News"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3565(25)12653-0","article-title":"Metabolism of methylenedioxymethamphetamine: formation of dihyroxymethamphetamine and a quinone identified as a glutathione adduct","volume":"254","author":"Hiramatsu","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2005.05.003","article-title":"Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo","volume":"81","author":"Johanson","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-006-0523-z","article-title":"Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine","volume":"189","author":"Kueh","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-133-12-200012190-00012","article-title":"Cardiovascular effects of 3,4-methylenedioxymethamphetamine: a double-blind, placebo-controlled trial","volume":"133","author":"Lester","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","article-title":"Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans","volume":"290","author":"Mas","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2017","series-title":"Press Release: FDA Grants Breakthrough Therapy Designation for MDMA-assisted Psychotherapy for PTSD, Agrees on Special Protocol Assessment for Phase 3 Trials","author":"MAPS (Multidisciplinary Association for Psychedelic Studies)","key":"10.1016\/j.drugalcdep.2020.107850_bib0115"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/j.2051-5545.2010.tb00254.x","article-title":"The long-term costs of traumatic stress: intertwined physical and psychological consequences","volume":"9","author":"McFarlane","year":"2010","journal-title":"World Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-2999(97)00044-7","article-title":"2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+\/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations","volume":"323","author":"Miller","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of {+\/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269881112456611","article-title":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study","volume":"27","author":"Mithoefer","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0140","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007691-200404000-00008","article-title":"The role of metabolism in 3,4-(\u00b1)-methylenedioxyamphetamine and 3,4-(\u00b1)-methylenedioxymethamphetamine (ecstasy) toxicity","volume":"26","author":"Monks","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.114.214288","article-title":"Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats","volume":"350","author":"Mori","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","key":"10.1016\/j.drugalcdep.2020.107850_bib0160"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (\u00b1 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0170","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0269881118806297","article-title":"3,4-Methylenedioxymethamphetamine (MDMA)- assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized controlled trial","volume":"32","author":"Ot\u2019alora","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/02791072.2014.873690","article-title":"The potential dangers of using MDMA for psychotherapy","volume":"46","author":"Parrott","year":"2014","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/tx00022a004","article-title":"Transformation of dopamine and alpha-methyldopamine by NG108-15 cells: formation of thiol adducts","volume":"4","author":"Patel","year":"1991","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0185","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0022-3565(25)11083-5","article-title":"Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations","volume":"261","author":"Ricaurte","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0893-133X(01)00366-9","article-title":"The acute and chronic effects of MDMA (\u201cecstasy\u201d) on cortical 5-HT2A receptors in rat and human brain","volume":"26","author":"Reneman","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0091-3057(87)90474-6","article-title":"MDMA as a discriminative stimulus: isomeric comparisons","volume":"27","author":"Schechter","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0200","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/JCP.0000000000000962","article-title":"Methylenedioxymethamphetamine (MDMA) in psychiatry: pros, cons, and suggestions","volume":"38","author":"Schenk","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bph.12423","article-title":"Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats","volume":"171","author":"Schindler","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)22673-8","article-title":"Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine","volume":"240","author":"Schmidt","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.07.008","article-title":"Oxytocin receptor gene polymorphisms, attachment, and PTSD: results from the National Health and Resilience in Veterans study","volume":"94","author":"Sippel","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0041-008X(88)90285-2","article-title":"Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)","volume":"94","author":"Slikker","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10879-017-9379-2","article-title":"Current perspective on MDMA-assisted psychotherapy for posttraumatic stress disorder","volume":"48","author":"Thal","year":"2018","journal-title":"J. Contemp. Psychother."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0230","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0269881117691569","article-title":"Safety pharmacology of acute MDMA administration in healthy subjects","volume":"31","author":"Vizeli","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1348\/000712600161772","article-title":"Working memory deficits in current and previous users of MDMA (\u2019ecstasy\u2019)","volume":"91","author":"Wareing","year":"2000","journal-title":"Br. J. Psychol."},{"key":"10.1016\/j.drugalcdep.2020.107850_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4303\/jdar\/235976","article-title":"Analysis of the acquisition of drug discrimination reveals differences between a high versus low training dose of \u00b13,4-methylenedioxymethamphetamine (MDMA)","volume":"5","author":"Webster","year":"2016","journal-title":"J. Drug Alcohol Res."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620300156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620300156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:01:28Z","timestamp":1759827688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620300156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"alternative-id":["S0376871620300156"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107850","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107850"}}